Examinant per Autoria "Galindo-Campos, Miguel A."
Mostrant 1 - 4 de 4
Resultats per pàgina
Opcions d'ordenació
Ítem Accés Obert Impact of DNA damage response-targeted therapies on the immune response to tumours(MDPI, 2021) Lutfi, Nura; Galindo-Campos, Miguel A.; Yélamos López, José
Ítem Accés Obert MET Inhibitors in Small Cell Lung Cancer: From the Bench to the Bedside(MDPI, 2019) Hardy-Werbin, Max; del Rey-Vergara, Raúl; Galindo-Campos, Miguel A.; Moliner Jiménez, Laura; Arriola Aperribay, Edurne
Ítem Accés Obert PARP-1/PARP-2 double deficiency in mouse T cells results in faulty immune responses and T lymphomas(Nature Publishing Group, 2017) Navarro, Judith; Gozalbo-López, Beatriz; Méndez, Andrea C.; Dantzer, Françoise; Schreiber, Valérie; Martínez, Carlos; Arana, David M.; Farrés, Jordi; Revilla-Nuin, Beatriz; Bueno, María F.; Ampurdanés, Coral; Galindo-Campos, Miguel A.; Knobel, Philip A.; Segura-Bayona, Sandra; Martín Caballero, Juan; Stracker, Travis; Aparicio, Pedro; Del Val, Margarita; Yélamos López, José
Ítem Accés Obert Understanding specific functions of PARP-2: new lessons for cancer therapy.(e-Century Publishing, 2016) Ali, Syed O.; Khan, Farhaan A.; Galindo-Campos, Miguel A.; Yélamos López, José